trimethyloxamine has been researched along with pituitrin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, Q; Liu, M; Yang, J | 1 |
| Bielinska, K; Dadlez, M; Drapala, A; Gawrys, M; Huc, T; Konop, M; Pączek, L; Samborowska, E; Ufnal, M; Wyczalkowska-Tomasik, A; Zaorska, E | 1 |
2 other study(ies) available for trimethyloxamine and pituitrin
| Article | Year |
|---|---|
Trimethylamine-N-oxide (TMAO) increased aquaporin-2 expression in spontaneously hypertensive rats.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Blood Pressure; Hypertension; Kidney Medulla; Male; Methylamines; Osmolar Concentration; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tolvaptan; Vasopressins | 2019 |
Chronic, low-dose TMAO treatment reduces diastolic dysfunction and heart fibrosis in hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Fibrosis; Hypertension; Male; Methylamines; Myocardium; Natriuretic Peptide, Brain; Rats; Rats, Inbred SHR; Rats, Wistar; Vasopressins | 2018 |